National News
NAFDAC halts Artemether/Lumefantrine registration
The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
News17 hours agoPanic in Kebbi as bandits kill Vice Principal, kidnap students in night attack
-
News17 hours agoParents protest in Abuja over 16-Month unpaid allowances for students abroad
-
News17 hours agoPDP crisis deepens as Wike’s camp announces emergency BoT, NEC meetings
-
News2 days agoEthiopia confirms first Marburg virus outbreak, nine cases reported
-
News10 hours agoUNICAL ex-Law Dean Ndifon jailed Five Years for sexual harassment
-
News9 hours agoVeteran Journalist Dan Agbese, Newswatch co-founder, dies at 81
-
National News10 hours agoTinubu orders immediate rescue of 25 abducted Kebbi Schoolgirls
-
News15 hours agoCervical Cancer in Africa: WHO highlights major progress, calls for stronger action in 2025



